http://www.ssireview.org/articles/entry/15_minutes_with_victoria_hale/
Author: Nee, Eric
Source: Stanford Social Innovation Review
Year: 2007
Number of pages: 4
Abstract:
The pharmaceutical industry spends billions of dollars developing drugs to cure the ailments of wealthy Westerners, but very little to treat the diseases that kill millions of people a year in the developing world. Victoria Hale, who was recently awarded a MacArthur fellowship for her efforts, is trying to change all that.
Hale’s San Francisco-based nonprofit, Institute for OneWorld Health, is partnering with foundations, for-profit drug companies, NGOs, and governments around the world to bring these neglected drugs to market. She just scored her first success, receiving approval from the Indian government to sell a drug that cures visceral leishmaniasis. This disease, also known as black fever, kills 200,000 people a year and afflicts many times that number. And she has more drugs – to treat malaria, Chagas’ disease, and secretory diarrhea – in the pipeline.
In an interview with SSIR managing editor Eric Nee, Hale discusses what role the Bill & Melinda Gates Foundation plays in her organization, why for-profit drug companies are knocking at her door, and why her optimism about the chances of saving millions of lives every year is growing.
Available to Faculty Only. Faculty Member? Sign in / Register Here